Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 143,844 | 15 | 20 | 21 | 26 |
| Gross Profit | 143,844 | 15 | 20 | 21 | 26 |
| Operating Expenses | 12,011 | 12,992 | 13,490 | 12,173 | 11,494 |
| Operating Income | 131,833 | -12,977 | -13,470 | -12,152 | -11,468 |
| Interest Expense | 609 | 205 | 0 | 0 | 0 |
| Other Income | -982 | 155 | 137 | 109 | 112 |
| Pre-tax Income | 130,242 | -13,027 | -13,333 | -12,043 | -11,356 |
| Income Tax | 2,177 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 128,065 | -13,027 | -13,333 | -12,043 | -11,356 |
| Net Income | $128,065 | $-13,027 | $-13,333 | $-12,043 | $-11,356 |
| EPS Basic Total Ops | 5.61 | -0.58 | -0.60 | -0.54 | -0.51 |
| EPS Basic Continuous Ops | 5.64 | -0.58 | -0.60 | -0.54 | -0.51 |
| EPS Diluted Total Ops | 5.44 | -0.58 | -0.60 | -0.54 | -0.51 |
| EPS Diluted Continuous Ops | 5.47 | -0.58 | -0.60 | -0.54 | -0.51 |
| EBITDA(a) | $132,138 | $-12,738 | $-13,235 | $-11,891 | $-11,186 |